Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KETABI: S-ketamine vs. propofol for prehospital sedation in severe acute brain injury
2026-525588-41-00Phase 4Authorised
- Sponsor
- Capital Region of Denmark
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in traumatic brain injury (TBI), subarachnoid hemorrhage (SAH) and intracerebral hemorrhage (ICH) comparing S-ketamine arm with Propofol arm (2 arms). Primary endpoint: Lowest mean arterial pressure during intervention period. Planned start Aug 2026; status: authorised.
02
Drugs
esketaminepropofol
03
Conditions
traumatic brain injury (TBI)subarachnoid hemorrhage (SAH)intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2026-525588-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525588-41-00.